Health Reference Library

What does the full iron panel tell us beyond ferritin alone?

Last reviewed 29 April 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

A full iron panel measures four biomarkers: serum iron, total iron-binding capacity (TIBC), transferrin saturation (TSAT), and ferritin. Together they give substantially more information than ferritin alone, which is essential because ferritin is an acute-phase reactant. TSAT below 20% is consistent with iron deficiency. TSAT above 45% (women) or 50% (men) is the threshold for further haemochromatosis evaluation. Newer markers such as soluble transferrin receptor add further information but are not yet routinely available.

Free iron and ferritin result interpreter

Enter what you have. Your ferritin alone works; the other fields sharpen the reading. Nothing you enter leaves this device. Nothing is saved. No AI is used, only published UK guideline thresholds.

This tool gives educational interpretation of published evidence. It is not personal dosing advice and it does not diagnose. It knows nothing about your history, symptoms or other results. Interpreting your results over time, alongside everything else about you, is what Nutri365 does.

How it works

TIBC is upregulated in absolute iron deficiency (the body produces more transferrin to scavenge iron) and downregulated in anaemia of inflammation (hepatic transferrin production falls). This is the key distinguisher: low TIBC alongside low TSAT suggests anaemia of inflammation; high TIBC alongside low TSAT suggests absolute iron deficiency. Newer markers add information when ferritin is uninterpretable but are not yet universally available in NHS labs. These include soluble transferrin receptor (sTfR), reticulocyte haemoglobin content (CHr/RetHe), and hepcidin.

Safety profile

Iron studies are not interpretable for several weeks following blood transfusion or large iron infusion. sTfR assays are not standardised across laboratories. Reference ranges for all four markers vary by laboratory and population. Values must be interpreted against the local reporting laboratory reference range. Liver disease can produce markedly elevated ferritin due to hepatocellular release; alternative markers are preferred in that setting.

Special populations

Recent transfusion: iron studies are not interpretable for several weeks. Liver disease: ferritin elevated due to hepatocellular release; alternative markers preferred. Post-iron-supplementation context: serum iron and TSAT transiently elevated for hours after a dose, so testing follows an appropriate supplement-free interval (24 hours per AASM 2024 RLS guidance; 7-14 days per some haematology guidance for cleanest baseline).

Guideline positions

Iron deficiency operational thresholds: TSAT <20% is the consensus cut-off (BSG 2021, AGA 2020, AASM 2024 RLS context). Iron overload screening: TSAT persistently >45% in women or >50% in men triggers further evaluation per AASLD 2011 and EASL 2022. EASL 2022 combined criterion: TSAT >45% with ferritin >200 µg/L (women) or TSAT >50% with ferritin >300 µg/L (men and post-menopausal women). Fertrin 2020 (ASH Education Program) provides clinical synthesis of when each marker is most informative.

Practical framework

Pattern D (early haemochromatosis or other iron overload): TSAT persistently >45% (women) or >50% (men), ferritin elevated, normal or low TIBC. Investigate per AASLD 2011 / EASL 2022 algorithms including HFE genotyping. Pattern E (recent iron supplementation): serum iron transiently elevated, TSAT elevated for hours after a dose; re-test after appropriate iron-supplement-free interval. BSG 2021 recommends rechecking haemoglobin and serum ferritin at 4 weeks (early response) and 3 months (full response) after initiating iron repletion. EASL 2022 advises confirming an elevated TSAT with a second measurement. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: fasting is required for accurate iron studies. AASLD 2011 evidence review found fasting is no longer required for diagnostic accuracy, although some clinicians advise it to reduce variability. The TIBC distinction is the most useful biomarker pivot for distinguishing absolute iron deficiency (high TIBC) from anaemia of inflammation (low TIBC) when both show low TSAT. sTfR adds information when ferritin is uninterpretable due to inflammation.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Recent updates

Reviewed and corrected against sources on , ,

Sources

  1. Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RPH, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM 2021. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. PMID: 34497146 · DOI: 10.1136/gutjnl-2021-325210
  2. Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, Falck-Ytter Y 2020. AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia. Gastroenterology. PMID: 32810434 · DOI: 10.1053/j.gastro.2020.06.046
  3. World Health Organization 2020. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. World Health Organization (WHO).
  4. Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS 2025. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. Journal of Clinical Sleep Medicine. PMID: 39324694 · DOI: 10.5664/jcsm.11390
  5. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases 2011. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. PMID: 21452290 · DOI: 10.1002/hep.24330
  6. European Association for the Study of the Liver (lead authors: Zoller H, Schaefer B, Vanclooster A, Loustaud-Ratti V, Bardou-Jacquet E, Pietrangelo A; et al) 2022. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. PMID: 35662478 · DOI: 10.1016/j.jhep.2022.03.033
  7. Fertrin KY 2020. Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick?. Hematology Am Soc Hematol Educ Program. PMID: 33275757 · DOI: 10.1182/hematology.2020000132
  8. Mei Z, Addo OY, Jefferds MED, Flores-Ayala RC, Brittenham GM 2024. Physiologically based trimester-specific serum ferritin thresholds for iron deficiency in US pregnant women. Blood Advances. PMID: 38781318 · DOI: 10.1182/bloodadvances.2024013460
  9. NIH Office of Dietary Supplements. NIH Office of Dietary Supplements — Iron Fact Sheet for Health Professionals. NIH Office of Dietary Supplements (US government).

Related entries

Back to Iron overview